OnKure Therapeutics Stock (NASDAQ:OKUR)
Previous Close
$2.37
52W Range
$1.70 - $20.00
50D Avg
$2.46
200D Avg
$7.22
Market Cap
$31.21M
Avg Vol (3M)
$159.22K
Beta
0.41
Div Yield
-
OKUR Company Profile
OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.